The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1122
ISSUE1122
January 21, 2002
Budesonide (Entocort EC) For Crohn's Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Budesonide (Entocort EC) For Crohn's Disease
January 21, 2002 (Issue: 1122)
Budesonide (Entocort EC AstraZeneca), a locally active glucocorticosteriod widely used for inhalation treatment of allergic rhinitis and asthma (Medical Letter 2000; 42:19), has been approved for oral treatment of mild to moderate active...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.